The Atenolol Tablets, cataloged under National Stock Number 6505-01-336-6196, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mylan Pharmaceuticals Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-336-6196 |
| Primary Part Number | NDC00378-0218-01 |
| Item Name | Atenolol Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mylan Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00378-0218-01 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| NDC00093-0787-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| 463649 | Mckesson Corporation Dba Sky Packaging (USA) |
| Reference | Meaning |
|---|---|
| C07AB03 | 6/9 Informative reference only Who Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health |
| TENORMIN TABLETS | 5/9 Secondary reference Astrazeneca Lp |
NSN 6505-01-336-6196 is a Atenolol Tablets, manufactured by Mylan Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-336-6196 has 3 manufacturer part numbers on file: NDC00378-0218-01 (Mylan Pharmaceuticals Inc), NDC00093-0787-01 (Teva Pharmaceuticals Usa, Inc.), 463649 (Mckesson Corporation Dba Sky Packaging).
Key specifications for NDC00378-0218-01: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: ATENOLOL TABLETS 25MG 100S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.